Understanding the neurobiological factors underlying individual differences in impulsivity
may provide valuable insight into vulnerability to impulse control disorders. Recent
data implicate both the orbitofrontal cortex (OFC) and the dopaminergic system in
psychiatric disorders associated with high levels of impulsivity, including substance
abuse, mania and obsessive-compulsive disorder. However, the consequences of modulating
dopaminergic activity within the OFC on impulsive behaviour are largely unknown. The
effects of direct intra-OFC infusions of agonists and antagonists at the dopamine
D(1) and D(2) receptors were therefore assessed in rats performing the five-choice
serial reaction time test (5CSRT) of attention and motor impulsivity. Intra-OFC administration
of SCH23390, a D(1) receptor antagonist, decreased impulsive responding in highly
impulsive (HI) rats, but did not affect behaviour in less impulsive (LI) animals.
Furthermore, the D(2) agonist quinpirole caused significant deficits in task performance,
impairing accuracy, increasing omissions and decreasing the number of trials completed,
which resembled the effects of systemic administration. In contrast, the D(1) agonist
SKF 81297 had little effect on behaviour. Neither agonist increased impulsivity. These
data provide partial support for the suggestion that high levels of impulsivity are
associated with increased dopamine levels within the OFC, but further indicate that
simulating dopamine's actions selectively at the D(1) or D(2) receptor cannot reproduce
a highly impulsive phenotype. Dopaminergic activity within the OFC may therefore modulate
impulsivity indirectly, perhaps in conjunction with other neurotransmitter systems.
Furthermore, D(2)-mediated neurotransmission within the OFC could make a more fundamental
contribution to cognitive behaviour.
Copyright 2010 Elsevier B.V. All rights reserved.